Comparison of efficacy of efavirenz and nevirapine: lessons learned for cohort analysis in light of the 2NN Study.
Philip
P
Keiser
Naiel
N
Nassar
Beena
B
Yazdani
Laura
L
Armas
Sylvia
S
Moreno
D000480:Alkynes; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D048588:Benzoxazines; D015331:Cohort Studies; D003521:Cyclopropanes; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D019829:Nevirapine / Q000627:therapeutic use*; D010078:Oxazines / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012107:Research Design
D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; D019829:Nevirapine; C098320:efavirenz